Concepedia

Christopher L. Carroll

CL

Statistics

Publications

2

Citations

27

H-Index

2

Active since

2024

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Babraham Institute

Christopher L. Carroll is an author at The University of Texas MD Anderson Cancer Center specializing in cancer genetics, cancer genomics, and targeted cancer therapy.

ORCID

Publications per year

2024–2024

2

Publications

2

Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid Cancers

Christopher L. Carroll, Michael G. Johnson, Yanbing Ding et al. · Journal of Medicinal Chemistry · 2024 · 15 citations

, , +14

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

Patrick G. Pilié, Virginia Giuliani, Wei‐Lien Wang et al. · Clinical Cancer Research · 2024 · 12 citations · Full text

, , +17

1–2 of 2